Paragraph 3
The holder of the authorisation shall provide such information as may be requested by the licensing authority concerning the type and quantity of any investigational medicinal products F1or EAMS medicinal products which he imports.
Annotations
Textual amendments
- F1
Words in Sch. 7 Pt. 3 para. 3 inserted (15.4.2022) by The Human Medicines (Amendments Relating to the Early Access to Medicines Scheme) Regulations 2022 (S.I. 2022/352), regs. 1(2), 18(3)(b) (with reg. 19)